Development of a multi-target peptide for potentiating chemotherapy by modulating tumor microenvironment

Doxorubicin loaded liposomes modified with nRGD (nRGD-Lipo-Dox) have been developed to dramatically enhance antitumor efficacy of Dox by recognizing tumor vasculature, penetrating through tumor cells, as well as depleting TAMs.227